Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Preliminary Lineup of Presenters Set for 7th Annual New York Stem Cell Summit

August 25, 2011 10:40 am | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, Aug. 25, 2011 /- RRY Publications LLC today announced the preliminary lineup of presenters for the 7th Annual Stem Cell Summit. The Stem Cell Summit, an intensive one-day event, that allows attendees to learn about the latest developments in the stem cell marketplace,...

Stereotaxis to Present at the Stifel Nicolaus Healthcare Conference on September 7, 2011

August 25, 2011 8:39 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Aug. 25, 2011 /- Stereotaxis, Inc. (NASDAQ: STXS ) today announced that executive management will present at the Stifel Nicolaus Healthcare Conference to be held September 7-9, 2011 in Boston, MA.  Michael P. Kaminski, President and Chief Executive Officer of Stereotaxis,...

HeartSine® Technologies Donates Lifesaving AED to Camphill Special School

August 24, 2011 9:45 am | by Bio-Medicine.Org | News | Comments

NEWTOWN, Pa., Aug. 24, 2011 /- HeartSine® Technologies, Inc. ( ), a world leader in personal and public access defibrillators, announced the donation of the samaritan ® PAD 300P Public Access Defibrillator to Camphill Special School, a community and a school...


Framingham Heart study leader, Kannel, dies

August 24, 2011 5:43 am | by Mass High Tech: The Journal of New England Technology | News | Comments

One of the driving forces of the long-running, pioneering project known as the Framingham Heart Study died of cancer on Saturday at age 87.

VeraLight and Pear Healthcare Solutions Sign Canadian Distribution Agreement for SCOUT DS® Noninvasive Diabetes Screening Device

August 23, 2011 4:48 am | by Bio-Medicine.Org | News | Comments

ALBUQUERQUE, N.M. and TORONTO, Aug. 23, 2011 /- VeraLight Inc., the first company to develop an optical skin measurement for noninvasive diabetes screening, and Pear Healthcare Solutions Inc., a leading provider of in-pharmacy health screening and education services, today announced an...

Growing Heart Cells Just for You

August 22, 2011 8:45 pm | by Massachusetts Institute of Technology | News | Comments

What can heart cells generated from my blood tell me about my risk for disease-and about what drugs I should take if I get sick?

Visiting Wisconsin to See My Heart

August 22, 2011 8:44 pm | by Massachusetts Institute of Technology | News | Comments

David traveled to the headquarters of CDI in Madison to view his stem cells and his beating heart cells–and to meet the lab team who made and tested them.

Spaulding Clinical Announces Strategic Partnership with Clinigene International, India for Providing Comprehensive Early Clinical Solutions to Pharmaceutical and Biotech Clien...

August 22, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

WEST BEND, Wis., Aug. 22, 2011 /- Clinigene International Limited, an India-based Central and Bioanalytical Laboratory and Phase I-IV Clinical Research Organization, and Spaulding Clinical Research, LLC, US-based leading-edge Clinical Pharmacology, Cardiac Core Lab, and Medical Device...


First UK Patient Enrolled into Luminous™ Programme – Novartis' 30,000 Patient Observational Study in Ophthalmology

August 21, 2011 11:41 pm | by RealWire | News | Comments

Luminous, launched today, will provide long-term effectiveness, safety, and patient reported outcome data on Lucentis® (ranibizumab) in 30,000 patients in real-life settings across the worldFrimley, August 22 2011 - Novartis Pharmaceuticals UK Ltd (Novartis) has announced the...

The Leukemia & Lymphoma Society Available to Comment on FDA Approval of Seattle Genetics' Adcetris, First New Treatment for Hodgkin Lymphoma Since 1977

August 19, 2011 5:45 pm | by Bio-Medicine.Org | News | Comments

WHITE PLAINS, N.Y., Aug. 19, 2011 /- Today the Food and Drug Administration (FDA) approved Seattle Genetics' Adcetris to treat two types of rare blood cancers – Hodgkin lymphoma and anaplastic large cell lymphoma (ALCL). (Logo:

Tips for Reducing the Signs of Arthritis in Pets

August 18, 2011 11:42 am | by Bio-Medicine.Org | News | Comments

PLYMOUTH MEETING, Pa., Aug. 18, 2011 /- According to the Arthritis Foundation, arthritis affects one in every five adult dogs in the United States and is one of the most common sources of chronic pain that veterinarians treat. Pet owners can easily be overwhelmed by the variety of...

Polymedco Announces Publication in Epidemiologic Reviews

August 17, 2011 9:42 am | by Bio-Medicine.Org | News | Comments

CORTLANDT MANOR, N.Y., Aug. 17, 2011 /- Polymedco is pleased to announce a publication in Epidemiologic Review, "Organized Colorectal Cancer Screening in Integrated Health Care Systems" by Theodore R Levin, Laura Jamieson, Daniel A Burley, Juan Reyes, Michael Oehrli, and Cindy Caldwell...

Two-Year Follow-Up Data Show Outstanding Clinical Outcomes and Safety for OrbusNeich's Genousâ„¢ Stent in Patients at High Risk for Restenosis

August 16, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

HONG KONG, Aug. 16, 2011 /- OrbusNeich today announced that the that the company's Genous Stent showed no significant difference in the rate of target vessel failure (TVF) at two years compared to the Taxus Liberte™ paclitaxel-eluting stent in patients with de novo coronary artery...


CR Magazine Congratulates Cynthia Ryan, Ph.D., Clarion Award Recipient

August 16, 2011 6:40 am | by AACR | News | Comments

Tweet PHILADELPHIA — CR magazine, the AACR’s magazine for cancer survivors, their families and caregivers, congratulates contributing writer Cynthia Ryan, Ph.D., on her Clarion Award-winning article, “Homeless With Cancer,” which was published in CR’s Fall...

New Study Shows Modified Citrus Pectin Activates Powerful Immune Responses

August 16, 2011 2:43 am | by Bio-Medicine.Org | News | Comments

SANTA ROSA, Calif., Aug. 16, 2011 /- Groundbreaking research demonstrates the ability of a specific form of Modified Citrus Pectin (MCP) to greatly enhance immune function. The study found that MCP activated B-cells in a dose-dependent manner, and induced a highly significant...

THA Group Partners with Cardiocom Telehealth

August 15, 2011 6:47 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Aug. 15, 2011 /- THA Group, a free standing in-home health company serving coastal Georgia and South Carolina, announced that it will be partnering with Cardiocom® to expand its chronic telehealth program providing advanced home telehealth technology to patients with...

HeartWare to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference

August 12, 2011 10:45 am | by Bio-Medicine.Org | News | Comments

FRAMINGHAM, Mass and SYDNEY, Aug. 12, 2011 /- HeartWare International, Inc. (NASDAQ: HTWR ; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug...

University Hospitals and Centerre Healthcare Announce Joint Venture to Open Comprehensive Inpatient Rehabilitation Hospital

August 12, 2011 7:42 am | by Bio-Medicine.Org | News | Comments

CLEVELAND and NASHVILLE, Tenn., Aug. 12, 2011 /- University Hospitals (UH) in Cleveland, OH, and Nashville-based Centerre Healthcare Corporation announced today a joint venture to construct a comprehensive inpatient rehabilitation hospital in Beachwood, OH. Scheduled for completion in...

Newly-Published Colchicine Safety Data Provide First Evidence-Based Dosing Guidance to Avoid Potentially Serious Interactions With Commonly Prescribed Drugs

August 11, 2011 12:39 pm | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, Aug. 11, 2011 /- Newly-published results from a series of colchicine safety studies provide physicians with the first evidence-based dosing guidance for colchicine when co-administered with certain commonly prescribed drugs, helping doctors and patients avoid serious and...

Dentists, Pharmacists Raise Awareness of Medication-Induced Dry Mouth

August 11, 2011 9:42 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Aug. 11, 2011 /PRNewswire-USNewswire/ -- Leading dental and pharmacy organizations are teaming up to promote oral health and raise public awareness of dry mouth, a side effect commonly caused by taking prescription and over-the-counter medications.  More than 500 medications...

Althea Technologies Hosts Health and Wellness Week

August 11, 2011 3:44 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Aug. 11, 2011 /- Althea Technologies, Inc., a leading provider of development and manufacturing services for biotechnology and pharmaceutical companies, held its inaugural Health and Wellness Fair today. The fair is part of a weeklong wellness program, which includes daily...

Cook Medical's Doppler Blood Flow Monitor a Significant Advance for Free Flap Procedures

August 10, 2011 10:47 am | News | Comments

Technology leverages company's patented Doppler platform, providing surgeons with a direct vessel monitoring tool to assist in transplant and reconstructive surgeries

AACR Mourns the Loss of Two Champions of Biomedical Research

August 10, 2011 7:41 am | by AACR | News | Comments

Tweet PHILADELPHIA — The American Association for Cancer Research is deeply saddened by the loss of former National Institutes of Health (NIH) Director Bernadine P. Healy, M.D., and former Sen. Mark O. Hatfield, two distinguished leaders who separately championed the promise of...

Aprima and Health Care Strategies Join Forces to Improve the Financial Health of Physicians

August 10, 2011 7:41 am | by Bio-Medicine.Org | News | Comments

DALLAS, Aug. 10, 2011 /- Aprima Medical Software announced today the acquisition of Health Care Strategies (HCS), a leading provider of Revenue Cycle Management (RCM) services to physician offices throughout the U.S. HCS has consistently achieved significant gains in receivables...

GNS Healthcare Announces Collaboration With Bristol-Myers Squibb

August 10, 2011 7:41 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., Aug. 10, 2011 /- GNS Healthcare, Inc., (GNS) the leading healthcare analytics company focused on enabling personalized medicine to improve human health, today announced that it has entered into a collaboration with Bristol-Myers Squibb Company (NYSE: BMY ) focused on the...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.